BFRI BIOFRONTERA INC revenue, earnings and financials
For the quarter ended June 30, 2026, BIOFRONTERA INC reported revenue of $12.0M (up 32.9% from a year earlier), net income of −$604K and diluted EPS of −$0.05; over the last four quarters revenue was $46.2M and net income −$6.37M; for the fiscal year ended December 2025 revenue was $41.7M, up 11.7% on the year before.
BFRI annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $41.7M, gross profit n/a, operating income −$11.3M, net income −$10.5M (margin -25.3%), EPS −$1.04
- Fiscal year ended Dec 2024: revenue $37.3M, gross profit n/a, operating income −$17.2M, net income −$17.8M (margin -47.6%), EPS −$3.22
- Fiscal year ended Dec 2023: revenue $34.1M, gross profit n/a, operating income −$22.7M, net income −$20.1M (margin -59.1%), EPS −$13.02
- Fiscal year ended Dec 2022: revenue $28.7M, gross profit n/a, operating income −$18.6M, net income −$640K (margin -2.2%), EPS −$0.61
- Fiscal year ended Dec 2021: revenue $24.1M, gross profit n/a, operating income −$25.2M, net income −$37.7M (margin -156.5%), EPS −$4.28
BFRI quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $12.0M (up 32.9% year over year), net income −$604K, EPS −$0.05
- Quarter ended Mar 31, 2026: revenue $10.1M (up 17.4% year over year), net income −$4.75M, EPS −$0.41
- Quarter ended Dec 31, 2025 (from the annual report): revenue $17.1M (up 36.2% year over year), net income $5.64M, EPS $0.62
- Quarter ended Sep 30, 2025: revenue $6.99M (down 22.5% year over year), net income −$6.65M, EPS −$0.62
- Quarter ended Jun 30, 2025: revenue $9.03M (up 15.2% year over year), net income −$5.32M, EPS −$0.57
- Quarter ended Mar 31, 2025: revenue $8.59M (up 8.5% year over year), net income −$4.20M, EPS −$0.47
- Quarter ended Dec 31, 2024 (from the annual report): revenue $12.6M (up 18.5% year over year), net income −$1.40M, EPS $0.69
- Quarter ended Sep 30, 2024: revenue $9.01M (up 1.3% year over year), net income −$5.67M, EPS −$0.98
- Quarter ended Jun 30, 2024: revenue $7.84M (up 34.0% year over year), net income −$257K, EPS −$0.05
- Quarter ended Mar 31, 2024: revenue $7.91M (down 9.4% year over year), net income −$10.4M, EPS −$2.88
- Quarter ended Dec 31, 2023 (from the annual report): revenue $10.6M (up 4.4% year over year), net income $3.53M, EPS $4.45
- Quarter ended Sep 30, 2023: revenue $8.90M (up 105.8% year over year), net income −$6.34M, EPS −$4.64
- Quarter ended Jun 30, 2023: revenue $5.85M (up 31.2% year over year), net income −$9.84M, EPS −$7.23
- Quarter ended Mar 31, 2023: revenue $8.73M (down 10.4% year over year), net income −$7.48M, EPS −$5.60
- Quarter ended Dec 31, 2022 (from the annual report): revenue $10.1M (up 10.7% year over year), net income −$2.79M, EPS $2.23
- Quarter ended Sep 30, 2022: revenue $4.32M (down 0.3% year over year), net income −$2.57M, EPS −$2.26
- Quarter ended Jun 30, 2022: revenue $4.46M (down 23.9% year over year), net income −$850K, EPS −$0.90
- Quarter ended Mar 31, 2022: revenue $9.75M (up 105.5% year over year), net income $5.56M, EPS $0.32
- Quarter ended Dec 31, 2021 (from the annual report): revenue $9.17M, net income −$14.5M, EPS −$1.38
- Quarter ended Sep 30, 2021: revenue $4.33M, net income −$16.0M, EPS −$2.00
BFRI cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$13.4M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$10.3M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$24.9M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$16.2M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$26.7M, share buybacks n/a
BFRI balance sheet
- Jun 30, 2026: cash $4.66M, total assets $24.1M, total liabilities $18.1M, shareholders' equity $5.96M
- Mar 31, 2026: cash $6.32M, total assets $24.8M, total liabilities $18.7M, shareholders' equity $6.07M
- Dec 31, 2025: cash $6.39M, total assets $28.6M, total liabilities $18.1M, shareholders' equity $10.5M
- Sep 30, 2025: cash $3.42M, total assets $15.4M, total liabilities $18.0M, shareholders' equity −$2.58M
- Jun 30, 2025: cash $7.24M, total assets $20.1M, total liabilities $24.8M, shareholders' equity −$4.67M
- Mar 31, 2025: cash $1.79M, total assets $16.6M, total liabilities $16.1M, shareholders' equity $469K
- Dec 31, 2024: cash $5.91M, total assets $22.1M, total liabilities $17.7M, shareholders' equity $4.43M
- Sep 30, 2024: cash $2.87M, total assets $18.5M, total liabilities $13.0M, shareholders' equity $5.53M
What is BFRI's revenue?
BIOFRONTERA INC reported $46.2M of revenue over its last four quarters, through June 30, 2026.
Is BFRI profitable?
No. BIOFRONTERA INC lost $6.37M over the last four quarters.
What is BFRI's EPS?
Diluted earnings per share over the last four quarters were −$0.46; −$0.05 in the latest quarter.